Imatinib Mesylate (Gleevec) in the Treatment of 2 Patients with Philadelphia-Positive ALL Relapsing after Allogeneic Stem Cell Transplantation

被引：0
|
作者：
Keiji Sugimoto
Michiaki Mikoshiba
Kazuteru Ohashi
Hideki Akiyama
Hisashi Sakamaki
机构：
[1] Tokyo Metropolitan Komagome Hospital,Hematology Division
[2] Juntendo University School of Medicine,Hematology Division
来源：
International Journal of Hematology | 2002年 / 75卷
关键词：
Acute Lymphoblastic Leukemia; Chronic Myeloid Leukemia; Imatinib Mesylate; Allogeneic Stem Cell Transplantation; Leukemic Blast;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：440 / 442
页数：2
相关论文
共 50 条
  • [1] Imatinib mesylate (gleevec) in the treatment of 2 patients with Philadelphia-positive ALL relapsing after allogeneic stem cell transplantation
    Sugimoto, K
    Mikoshiba, M
    Ohashi, K
    Akiyama, H
    Sakamaki, H
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 75 (04) : 440 - 442
  • [2] Imatinib Mesylate (Gleevec®) And Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation
    Rivaud, E.
    Tcherakian, C.
    Metivier, A. -C.
    Neveu, H.
    Vernant, J. P.
    Couderc, L. J.
    Dhedin, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [3] Nilotinib and donor lymphocyte infusion in the treatment of Philadelphia-positive acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation and resistant to imatinib
    Tiribelli, M.
    Sperotto, A.
    Candoni, A.
    Simeone, E.
    Buttignol, S.
    Fanin, R.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S433 - S434
  • [4] Nilotinib and donor lymphocyte infusion in the treatment of Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL) relapsing after allogeneic stem cell transplantation and resistant to imatinib
    Tiribelli, Mario
    Sperotto, Alessandra
    Candoni, Anna
    Simeone, Erica
    Buttignol, Silvia
    Fanin, Renato
    LEUKEMIA RESEARCH, 2009, 33 (01) : 174 - 177
  • [5] NILOTINIB AND DONOR LYMPHOCYTE INFUSION IN THE TREATMENT OF PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PHALL) RELAPSING AFTER ALLOGENEIC STEM CELL TRANSPLANTATION AND RESISTANT TO IMATINIB
    Tiribelli, M.
    Sperotto, A.
    Candoni, A.
    Simeone, E.
    Buttignol, S.
    Fanin, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 430 - 430
  • [6] Imatinib mesylate treatment of patients with chronic myeloid leukaemia relapsing following allogeneic stem cell transplantation
    Conneally, E
    Carroll, P
    Neat, M
    Haslam, K
    Gately, K
    Ryan, J
    Lawler, M
    McCann, S
    BLOOD, 2004, 104 (11) : 248B - 249B
  • [7] Therapy with imatinib mesylate (Glivec) preceding allogeneic stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL)
    B Wassmann
    H Pfeifer
    U Scheuring
    SA Klein
    N Gökbuget
    A Binckebanck
    H Martin
    H Gschaidmeier
    D Hoelzer
    OG Ottmann
    Leukemia, 2002, 16 : 2358 - 2365
  • [8] Therapy with imatinib mesylate (Glivec) preceding allogeneic stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL)
    Wassmann, B
    Pfeifer, H
    Scheuring, U
    Klein, SA
    Gökbuget, N
    Binckebanck, A
    Martin, H
    Gschaidmeier, H
    Hoelzer, D
    Ottmann, OG
    LEUKEMIA, 2002, 16 (12) : 2358 - 2365
  • [9] Imatinib mesylate (ST1571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemias
    Shimoni, A
    Kröger, N
    Zander, AR
    Rowe, JM
    Hardan, I
    Avigdor, A
    Yeshurun, M
    Ben-Bassat, I
    Nagler, A
    LEUKEMIA, 2003, 17 (02) : 290 - 297
  • [10] Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemias
    A Shimoni
    N Kröger
    A R Zander
    J M Rowe
    I Hardan
    A Avigdor
    M Yeshurun
    I Ben-Bassat
    A Nagler
    Leukemia, 2003, 17 : 290 - 297
12345